Visit JCR Japan
Visit JCR Japan
Home
Who we are
Innovation
Pipeline
Patients & families
Our commitment
Partnerships
Investors & media
Our products
Contact us
Reports
Revision of consolidated financial forecasts for fiscal year ended Mar 31, 2026
by JCR Pharmaceuticals
FY2025 third quarter results briefing session script
by JCR Pharmaceuticals
FY2025-Q3 financial report (Oct. 1-Dec. 31, 2025)
by JCR Pharmaceuticals
Revision of consolidated financial forecasts for fiscal year ended March 31, 2026
by JCR Pharmaceuticals
Recognition of subsidy income as extraordinary income
by JCR Pharmaceuticals
FY2025 third quarter results briefing session material
by JCR Pharmaceuticals
Briefing session movie on the agreement with Italfarmaco
by JCR Pharmaceuticals
FY2025 second quarter results briefing session script
by JCR Pharmaceuticals
FY2025 second quarter results briefing session - movie
by JCR Pharmaceuticals
FY2025 Second quarter results briefing session material
by JCR Pharmaceuticals
1
2
3
4
5
Privacy Preference Center
Privacy Preferences
